Pediatric Infectious Disease

Register      Login

VOLUME 2 , ISSUE 3 ( July-September, 2020 ) > List of Articles

Case Files

From the Case Records of Kanchi Kamakoti CHILDS Trust Hospital: Fever with Vesiculobullous Lesions

Balasubramanian Sundaram, Sabapathy L Raj, Sumanth Amperayani, Silky Agrawal

Citation Information : Sundaram B, Raj SL, Amperayani S, Agrawal S. From the Case Records of Kanchi Kamakoti CHILDS Trust Hospital: Fever with Vesiculobullous Lesions. Pediatr Inf Dis 2020; 2 (3):109-113.

DOI: 10.5005/jp-journals-10081-1273

License: CC BY-NC 4.0

Published Online: 25-11-2020

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. http://errolozdalga.com/medicine/pages/KC/RashFever.RashVesiculobullous.4.10.11.html.
  2. Waddington CS, Snelling TL, Carapetis JR. Management of invasive group A streptococcal infections. J Infect 2014;69(Suppl 1):S63. DOI: 10.1016/j.jinf.2014.08.005.
  3. Primary immunodeficiency diseases 278 CME August 2012 Vol. 30 No.8.
  4. Schröder A, Gerin A, Firth GB, et al. A systematic review of necrotising fasciitis in children from its first description in 1930 to 2018. BMC Infect Dis 2019;19(1):317. DOI: 10.1186/s12879-019-3941-3.
  5. Misiakos EP, Bagias G, Patapis P, et al. Current concepts in the management of necrotizing fasciitis. Front Surg 2014;1:36. DOI: 10.3389/fsurg.2014.00036.
  6. Wang YS, Wong CH, Tay YK. Staging of necrotizing fasciitis based on the evolving cutaneous features. Int J Dermatol 2007;46(10):1036–1041. DOI: 10.1111/j.1365-4632.2007.03201.x.
  7. Conley ME, Rohrer J, Minegishi Y. X-linked agammaglobulinemia. Clin Rev Allergy Immunol 2000;19(2):183. DOI: 10.1385/CRIAI:19:2:183.
  8. Ochs HD, Stiehm ER, Winkelstein JA. Antibody deficiencies. Immmunologic disorders in infants and children Stiehm ER, Ochs HD, Winkelstein JA, ed., Philadelphia: Elsevier/Sanders; 2004. p. 356.
  9. Nelson – aminoglygoside.
  10. Bowers DR, Liew Y-X, Lye DC, et al. Outcomes of appropriate empiric combination versus monotherapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2013;57(3):1270–1274. DOI: 10.1128/AAC.02235-12.
  11. Paul M, Leibovici L. Combination therapy for Pseudomonas aeruginosa bacteremia: Where do we stand? Clin Infect Dis 2013;57(2):217–220. DOI: 10.1093/cid/cit220.
  12. Biscaye S, Demonchy D, Afanetti M, et al. Ecthyma gangrenosum, a skin manifestation of Pseudomonas aeruginosa sepsis in a previously healthy child. Medicine 2017;96(2):e5507. DOI: 10.1097/MD.0000000000005507.
  13. Speirs CF, Selwyn S, Nicholson DN. Hypogammaglobulinaemia presenting as Pseudomonas septicaemia. Lancet 1963;11(7310):710–713. DOI: 10.1016/S0140-6736(63)90350-7.
  14. de Almeida JFL, Sztajnbok J, Troster EJ. Pseudomonas aeruginosa septic shock associated with ecthyma gangrenosum in an infant with agammaglobulinemia. Rev Inst Med Trop S Paulo 2002;44(3):167–169. DOI: 10.1590/S0036-46652002000300010.
  15. Chan YH, Chong CY, Puthucheary J, et al. Ecthyma gangrenosum: a manifestation of Pseudomonas sepsis in three paediatric patients. Singapore Med J 2006;47:1080–1083.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.